Envoy Medical (COCH) Enterprise Value (2021 - 2026)

Envoy Medical has disclosed Enterprise Value across 6 years of filings, most recently posting -$25.3 million for Q1 2026.

• Enterprise Value for Q1 2026 came in at -$25.3 million, down 375.36% year-over-year; the trailing twelve-month figure through Mar 2026 was -$25.3 million (down 375.36% YoY), and the FY2025 annual result was -$3.7 million, up 31.81% from the prior year.
• Enterprise Value came in at -$25.3 million for Q1 2026 at Envoy Medical, down from -$3.7 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of -$68000.0 in Q2 2023 to a low of -$25.3 million in Q1 2026.
• The 5-year median for Enterprise Value is -$4.0 million (2023), against an average of -$5.5 million.
• Across the five-year window, Enterprise Value jumped 94.1% in 2022 and sank 7264.31% in 2023, its largest moves.
• Envoy Medical's Enterprise Value stood at -$183000.0 in 2022, then plunged by 2205.46% to -$4.2 million in 2023, then declined by 29.96% to -$5.5 million in 2024, then jumped by 31.81% to -$3.7 million in 2025, then tumbled by 575.34% to -$25.3 million in 2026.
• The last three Enterprise Value figures came in at -$25.3 million (Q1 2026), -$3.7 million (Q4 2025), and -$3.6 million (Q3 2025), per Business Quant data.